832582497	832582497	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
85492893	85492893	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9321886	9321886	CD	B-NP	O
|	|	CC	I-NP	O
4/29/2006	4/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
bradycardia	bradycardia	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/12/2006	3/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/25/2006	5/25/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BANDEL	BANDEL	NNP	B-NP	O
,	,	,	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
MAYNARD	MAYNARD	NNP	I-NP	O
775-92-05-9	775-92-05-9	NNP	I-NP	O
Wioakst.stock	Wioakst.stock	NNP	I-NP	O
Pa	Pa	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/18/06	5/18/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GETTYS	GETTYS	NNP	B-NP	O
,	,	,	O	O
PALMER	PALMER	NNP	B-NP	O
NEIL	NEIL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
BACITRACIN	BACITRACIN	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
ulceration	ulceration	NN	B-NP	O
on	on	IN	B-PP	O
toes	toe	NNS	B-NP	O
.	.	.	O	O

CALTRATE	CALTRATE	NN	B-NP	O
600	600	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q12H	Q12H	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

COLACE	COLACE	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
ULTRAVATE	ULTRAVATE	JJ	I-NP	O
0.05	0.05	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HALOBETASOL	HALOBETASOL	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OINTMENT	OINTMENT	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
VICODIN	VICODIN	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
HYDROCODONE	HYDROCODONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-VP	O
APAP	APAP	NN	B-NP	B-protein
500MG	500MG	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
7/28	7/28	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/19/06	3/19/06	CD	B-NP	O
by	by	IN	B-PP	O
PITTSLEY	PITTSLEY	NNP	B-NP	O
,	,	,	O	O
WESLEY	WESLEY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NNP	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/21/06	2/21/06	CD	B-NP	O
by	by	IN	B-PP	O
SARNOWSKI	SARNOWSKI	NNP	B-NP	O
,	,	,	O	O
KEN	KEN	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
Override	Override	NN	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/18/06	8/18/06	CD	B-NP	O
by	by	IN	B-PP	O
OBRION	OBRION	NNP	B-NP	O
,	,	,	O	O
JULIAN	JULIAN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
210821160	210821160	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/18/06	5/18/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
URSODIOL	URSODIOL	NNP	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
ZINC	ZINC	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
220	220	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
1	1	CD	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Estrada	Estrada	NNP	I-NP	O
pcp	pcp	NN	I-NP	O
5/14	5/14	CD	I-NP	O
@	@	NN	I-NP	O
8	8	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Castelo	Castelo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
vascular	vascular	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10/24/06	10/24/06	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
lower	low	JJR	B-NP	O
ext	ext	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
bradycardia	bradycardia	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
R	R	NNP	I-NP	O
LE	LE	NNP	I-NP	O
ulcer	ulcer	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
bradycardia	bradycardia	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
lower	low	JJR	B-NP	O
ext	ext	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
68y/o	68y/o	CD	B-NP	O
obese	obese	JJ	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
PBC	PBC	NN	B-NP	B-cell_type
,	,	,	O	O
CRI	CRI	NN	B-NP	O
p/w	p/w	NN	I-NP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
painful	painful	JJ	B-NP	O
R	R	NN	I-NP	O
anterior	anterior	JJ	I-NP	O
shin	shin	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
and	and	CC	O	O
swollen	swell	VBN	B-NP	O
R	R	NN	I-NP	O
calf	calf	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
ulceration	ulceration	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
got	get	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
mobility	mobility	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
b/l	b/l	VB	I-VP	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
F/C/CP	F/C/CP	NN	I-NP	O
/	/	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
trauma	trauma	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
insect	insect	NN	I-NP	O
bites	bite	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
pets	pet	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
travel	travel	NN	I-NP	O
.	.	.	O	O

ED	ED	NNP	B-NP	O
VS	VS	NNP	I-NP	O
:	:	:	O	O
97	97	CD	B-NP	O
50130/77	50130/77	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
ancef	ancef	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
primary	primary	JJ	B-NP	O
biliary	biliary	JJ	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
hyperparathyridism	hyperparathyridism	NN	B-NP	O
2/2	2/2	CD	I-NP	O
CRI	CRI	NN	I-NP	O
,	,	,	O	O
colovesicular	colovesicular	JJ	B-NP	O
fistula	fistula	NN	I-NP	O
repair	repair	NN	I-NP	O
1/22	1/22	CD	I-NP	O
***	***	SYM	I-NP	O
Meds	Med	NNS	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
ursodiol	ursodiol	NN	B-NP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
caltrate	caltrate	NN	B-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
vicodin	vicodin	NN	B-NP	O
***	***	SYM	I-NP	O
NKDA	NKDA	NN	I-NP	B-protein
***	***	SYM	B-NP	O
Exam	Exam	NN	I-NP	O
:	:	SYM	I-NP	O
T	T	NN	I-NP	O
=	=	SYM	B-VP	O
97	97	CD	B-NP	O
HR	HR	NN	I-NP	O
=	=	SYM	B-VP	O
34-51	34-51	CD	B-NP	O
NSR	NSR	NN	I-NP	B-protein
BP	BP	NN	I-NP	I-protein
=	=	SYM	B-VP	O
138/71	138/71	CD	B-NP	O
R	R	NN	I-NP	O
16	16	CD	B-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Obese	Obese	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
Distant	Distant	NN	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
.	.	.	O	O

Nl	Nl	NN	B-NP	B-protein
s1	s1	NN	I-NP	I-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
.	.	.	O	O

CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

Abd	Abd	NNP	B-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
w	w	VBP	B-VP	O
/	/	SYM	B-NP	O
chronic	chronic	JJ	I-NP	O
brwany	brwany	JJ	I-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

2	2	CD	B-NP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
cm	cm	NN	I-NP	O
stage	stage	NN	I-NP	O
3	3	CD	I-NP	O
ulder	ulder	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	B-protein
shin	shin	NN	I-NP	I-protein
.	.	.	O	O

bilaterll	bilaterll	NN	B-NP	O
hammer	hammer	NN	I-NP	O
toe	toe	NN	I-NP	O
at	at	IN	B-PP	O
second	second	JJ	B-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

RLE	RLE	NN	B-NP	O
>	>	SYM	I-NP	O
LLE	LLE	NN	I-NP	O
.	.	.	O	O

Area	Area	NN	B-NP	O
surrounding	surround	VBG	B-VP	O
ulcer	ulcer	NN	B-NP	O
of	of	IN	B-PP	O
warmth/tenderness	warmth/tenderness	NN	B-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
foot	foot	NN	I-NP	O
films	film	NNS	I-NP	O
-	-	:	O	O
no	no	DT	B-NP	O
osteo	osteo	NN	I-NP	B-protein
LENIS	LENIS	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
DVT	DVT	NN	I-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.8	1.8	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BL	BL	NNS	I-NP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
-RRB-	-RRB-	SYM	O	O
HCT	HCT	NN	B-NP	B-protein
37.5	37.5	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
35-37	35-37	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
plt	plt	NN	B-NP	O
253	253	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
6.05	6.05	CD	I-NP	O
***	***	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
68F	68F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
presenting	present	VBG	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
RLE	RLE	NN	I-NP	B-protein
ulcer	ulcer	NN	I-NP	I-protein
and	and	CC	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
's	's	POS	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
4-6	4-6	NN	B-NP	O
sec	sec	NN	I-NP	O
pauses	pause	NNS	I-NP	O
,	,	,	O	O
asx	asx	NN	B-NP	O
,	,	,	O	O
evaluated	evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
PPM	PPM	NN	B-NP	B-protein
at	at	IN	B-PP	O
present	present	NN	B-NP	O
.	.	.	O	O

**	**	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
R	R	NN	I-NP	I-protein
lower	low	JJR	B-NP	O
ext	ext	JJ	I-NP	O
Ulcer	Ulcer	NN	I-NP	O
and	and	CC	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-	-	HYPH	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
initially	initially	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
nafcillin	nafcillin	NN	B-NP	O
IV	IV	CD	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Ecoli	Ecoli	NNP	B-NP	O
and	and	CC	I-NP	O
Enterobacter	Enterobacter	NNP	I-NP	O
,	,	,	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-VP	O
cipro	cipro	VB	I-VP	O
.	.	.	O	O

Abx	Abx	NN	B-NP	B-protein
were	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
cipro	cipro	NN	B-NP	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
provide	provide	VB	I-VP	O
coverage	coverage	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
gram	gram	NN	I-NP	O
negatives	negative	NNS	I-NP	O
growing	grow	VBG	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
cover	cover	VB	B-VP	O
her	her	PRP$	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
abx	abx	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
additional	additional	JJ	B-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cipro	cipro	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
but	but	CC	O	O
LENIS	LENIS	NN	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Zinc	Zinc	NNP	B-NP	O
and	and	CC	I-NP	O
Vit	Vit	NNP	I-NP	B-protein
C	C	NNP	I-NP	I-protein
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
need	need	VB	I-VP	O
Wound	Wound	NN	B-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
NS	NS	NN	B-NP	O
wet	wet	JJ	B-ADJP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
very	very	RB	B-NP	O
weak	weak	JJ	I-NP	O
LE	LE	NN	I-NP	O
pulse	pulse	NN	I-NP	O
so	so	RB	B-NP	O
vascualar	vascualar	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
+	+	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
by	by	IN	B-PP	O
doppler	doppler	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
get	get	VB	I-VP	O
umaboots	umaboot	NNS	B-NP	O
and	and	CC	O	O
ABI	ABI	NNP	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
followup	followup	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
's	's	POS	B-NP	O
during	during	IN	B-PP	O
sleep	sleep	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
,	,	,	O	O
esecially	esecially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
CRI	CRI	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
tachyarrythmia	tachyarrythmia	NN	I-NP	O
on	on	IN	B-PP	O
Tele	Tele	NNP	B-NP	O
.	.	.	O	O

Good	Good	JJ	B-NP	O
HR	HR	NN	I-NP	O
response	response	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
actviity	actviity	NN	B-NP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
70s	70	NNS	B-NP	O
.	.	.	O	O

Evaluated	Evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
PPM	PPM	NN	I-NP	B-protein
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
is	be	VBZ	B-VP	O
assymptomatic	assymptomatic	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
OSA	OSA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
improve	improve	VB	I-VP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
OSA	OSA	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ENdo	ENdo	NNP	I-NP	O
-	-	HYPH	O	O
fasting	fast	VBG	B-VP	O
glucose	glucose	NN	B-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
HGA1C	HGA1C	NN	B-NP	B-protein
-5.4	-5.4	CD	I-NP	I-protein
.	.	.	O	O

***	***	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Renal	Renal	JJ	I-NP	O
-	-	HYPH	I-NP	O
CRI	CRI	NN	I-NP	B-protein
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

take	take	VB	B-VP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
ulcer	ulcer	NN	B-NP	O
or	or	CC	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
worsens	worsen	NNS	I-NP	O
or	or	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
improve	improve	VB	I-VP	O
after	after	IN	B-SBAR	O
antibiotics	antibiotic	NNS	B-NP	O
please	please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	B-protein
doctor	doctor	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

stop	stop	VB	B-VP	O
taking	take	VBG	I-VP	O
atenolol	atenolol	NN	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

New	New	JJ	B-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
cipro	cipro	NN	B-NP	O
,	,	,	O	O
ascorbic	ascorbic	JJ	B-NP	O
acid	acid	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
vit	vit	NN	I-NP	O
C	C	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
zinc	zinc	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Appt	Appt	NN	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
study	study	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
appt	appt	NN	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

6	6	CD	B-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
care	care	NN	I-NP	O
:	:	:	O	O
BID	BID	NN	B-NP	O
wet	wet	JJ	B-ADJP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
NS	NS	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

d/c	d/c	NN	B-NP	O
atenolol	atenolol	NN	I-NP	O
,	,	,	O	O
avouid	avouid	NN	B-NP	B-protein
nodal	nodal	JJ	I-NP	I-protein
blocking	block	VBG	I-NP	I-protein
agents	agent	NNS	I-NP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
-	-	HYPH	B-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
appt	appt	NN	B-NP	O
date	date	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
after	after	IN	B-PP	O
tx	tx	NN	B-NP	O
for	for	IN	B-PP	O
OSA	OSA	NNP	B-NP	O
,	,	,	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
abx	abx	NN	I-NP	O
course	course	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
5	5	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cipro	cipro	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gleeson	Gleeson	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MANGRICH	MANGRICH	NNP	B-NP	O
,	,	,	O	O
VALENTINE	VALENTINE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HN46	HN46	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/18/06	5/18/06	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

